Morinamide

From Wikipedia, the free encyclopedia

Morinamide

Systematic (IUPAC) name
N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	?
Identifiers
CAS number	952-54-5
ATC code	J04AK04
PubChem	CID 70374
UNII	8CFL28PA3W^Y
KEGG	D07248^Y
Chemical data
Formula	C₁₀H₁₄N₄O₂
Mol. mass	222.244 g/mol
Y (what is this?) (verify)

Morinamide (or morphazinamide, or morinamid) is a drug used in the treatment of tuberculosis.^[1]

References

↑ Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G (1993). "Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks". Riv Eur Sci Med Farmacol 15 (3-4): 171–4. PMID 7761665.

Antimycobacterials, including tuberculosis treatment and leprostatic agents (J04)

Rifamycins/ RNA polymerase inhibitor	Rifampicin^# Rifabutin Rifapentine

Antifolates/DSI	Dapsone^# Acedapsone Aldesulfone sodium

ASA	4-Aminosalicylic acid^# (Calcium aminosalicylate Sodium aminosalicylate)

Aminoglycosides	Amikacin^# Capreomycin^# Kanamycin^# Streptomycin^#

Oxazolidone	Linezolid

Peptidoglycan layer	Alanine analogue: Cycloserine^#

Arabinogalactan layer	Ethylenediamine/arabinosyltransferase inhibitor: Ethambutol^# SQ109^†

Mycolic acid layer	Hydrazides/mycolic acid synth. inhibition: Isoniazid^# Thiocarbamides: Ethionamide^# Prothionamide Thiocarlide

Other/unknown

Combinations

bact (clas)

gr+f/gr+a (t)/gr-p (c)/gr-o

drug (J1p, w, n, m, vacc)

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.